Package 76420-338-60

{"route": ["ORAL"], "spl_id": "3423349e-5bea-b5eb-e063-6394a90a6241", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["313412", "313413"], "spl_set_id": ["2f460275-565f-4737-a3df-bf80b9acc268"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (76420-338-00)", "package_ndc": "76420-338-00", "marketing_start_date": "20250502"}, {"sample": false, "description": "150 TABLET in 1 BOTTLE (76420-338-15)", "package_ndc": "76420-338-15", "marketing_start_date": "20250502"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (76420-338-30)", "package_ndc": "76420-338-30", "marketing_start_date": "20250502"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (76420-338-60)", "package_ndc": "76420-338-60", "marketing_start_date": "20250502"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (76420-338-90)", "package_ndc": "76420-338-90", "marketing_start_date": "20250502"}], "brand_name": "Tizanidine", "product_id": "76420-338_3423349e-5bea-b5eb-e063-6394a90a6241", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "76420-338", "generic_name": "Tizanidine", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tizanidine", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA076416", "marketing_category": "ANDA", "marketing_start_date": "20031211", "listing_expiration_date": "20261231"}